InModeSTU:154 -0.47%81 Gross Margin % is 75.05% as of Mar. 2026, which is 10% below its 10-year median of 83.82. GuruFocus rates STU:154 with a GF Score™ of 81/100 and a GF Value™ of €17.07 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 804 Medical Devices & Instruments companies, InMode ranks better than 89.43% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. InMode's Gross Profit for the
three
months ended in Mar. 2026 was €53.2 Mil. InMode's Revenue for the
three
months ended in Mar. 2026 was €70.9 Mil. Therefore, InMode's Gross Margin % for the quarter that ended in Mar. 2026 was 75.05%.
Warning Sign:
InMode Ltd gross margin has been in long-term decline. The average rate of decline per year is -1.6%.
The historical rank and industry rank for InMode's Gross Margin % or its related term are showing as below:
STU:154'
s Gross Margin % Range Over the Past 10 Years
Min: 77.84 Med: 83.82 Max: 87.06
Current: 77.84
During the past 9 years, the highestGross Margin % of InMode was 87.06%. The lowest was 77.84%. And the median was 83.82%.
STU:154's Gross Margin % is ranked better than 89.43% of 804
companies
in the Medical Devices & Instruments industry
Industry Median: 51.985
vs STU:154: 77.84
InMode had a gross margin of 75.05% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for InMode was -1.60% per year.
InMode (STU:154) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
InMode had a gross margin of 75.05% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
InMode Gross Margin % Related Terms
InMode Gross Margin % Historical Data
* Premium members only.
The historical data trend for InMode's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:154 vs SIBN, CBLL, BBNX: Gross Margin % Comparison
For the Medical Devices subindustry, InMode's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
InMode Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, InMode's Gross Margin % distribution charts can be found below:
* The bar in red indicates where InMode's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
InMode (STU:154) has a Gross Margin % of 75.05% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on InMode and its competitors. This is 10% below median its historical median of 83.82. Over the past decade, InMode's Gross Margin % has ranged from 77.84 to 87.06. According to the industry distribution chart, InMode ranks #85 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 10.6%.
Is InMode's Gross Margin % too high?
InMode's current Gross Margin % of 75.05% is 10% below median its 10-year median of 83.82. Over the past 10 years, this metric has ranged from a low of 77.84 to a high of 87.06. The Medical Devices & Instruments industry median Gross Margin % is 51.99. InMode's value of 75.05% is 44.4% above this industry median. Based on the distribution chart, InMode ranks #85 out of 804 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, InMode has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does InMode's Gross Margin % compare to SIBN and CBLL?
According to the Medical Devices & Instruments industry distribution chart, InMode ranks #85 out of 804 companies for Gross Margin %. This places InMode in the top 11% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 51.99. InMode's value of 75.05% is 44.4% above this benchmark. Historically, InMode's own Gross Margin % has ranged from 77.84 to 87.06 over the past decade. While the company's 10-year median is 83.82 vs. the industry median of 51.99, InMode has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 51.99, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. InMode's current Gross Margin % of 75.05% is 44.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on InMode and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 51.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. InMode's current Gross Margin % is 75.05%, which is 10% below median its own 10-year median of 83.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InMode stock overvalued right now?
Based on GuruFocus' analysis, InMode (STU:154) is currently considered Modestly Undervalued. The stock's GF Value™ is €17.07, compared to a current price of €12.71 — trading 25.5% below its estimated fair value. The current Gross Margin % is 75.05%, which is 10% below median its 10-year median of 83.82 and 44.4% above the Medical Devices & Instruments industry median of 51.99. InMode's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For InMode (STU:154), the current Gross Margin % is 75.05% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is InMode (STU:154) Overvalued in 2026?
Based on GuruFocus' analysis, InMode stock appears to be undervalued.
The current stock price of €12.71 is trading 25.5% below its estimated GF Value™ of €17.07.
GuruFocus considers InMode to be Modestly Undervalued.
Key valuation signals for STU:154:
Gross Margin %: 75.05% (10% below median its 10-year median of 83.82)
GF Value™: €17.07 vs. price of €12.71 (25.5% below fair value)
Industry Position: 44.4% above the Medical Devices & Instruments median (#85 of 804)
No single metric tells the full story. See the STU:154 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
81GF Score
Get the complete analysis for STU:154
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:154 has been successfully added to your 
